Skip to main content
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Radiation Oncology

Radiation Technology at Temple

Fox Chase Cancer Center at Temple University Hospital houses three Elekta linear accelerators, including a Synergy® S, a Gamma Knife®, a dedicated CT scanner, a Nucletron 32-channel microSelectron® HDR Brachytherapy unit, and a BSD hyperthermia unit.  Learn  about the radiation oncology services offered at Fox Chase Cancer Center main campus and Fox Chase Cancer Center-Buckingham.

Dedicated CT Scanner

Offers patients the convenience of receiving their treatment planning CT scans in the Radiation Oncology department. 

The Leksell 4c Gamma Knife

Merges CT, MRI, angiograms and PET scans to ensure precise treatment of brain lesions, arteriovenous malformations (AVMs) and trigeminal neuralgia. This sophisticated unit focuses hundreds of separate cobalt radiation beams at the brain target, allowing safer, faster and more effective therapy.

The Elekta Synergy S

Is an integrated 3D volume imaging system that allows clinicians to address the time lag between imaging and treatment delivery to enhance accuracy. Any necessary adjustments in the patient's position can be made immediately to ensure that radiation is directed precisely at the target at all times.

Tumors, lesions and malformations throughout the body, as well as sites within the brain, can be treated with the Synergy S.

VMAT

VMAT is the only arc therapy solution that can deliver treatments in either one or several rotations of the linear accelerator. The goal is to provide an optimal clinical result for each individual patient. Temple's VMAT solution uses patient-protected technology for safely and efficiently delivering multiple arcs. Play the animation below to see VMAT in action.

The Nucletron 32-channel microSelectron HDR Brachytherapy Unit

Combines 3D treatment planning with image fusion capabilities and varieties of CT/MRI-compatible applicators.

The BSD Hyperthermia System

Uses focused microwave energy to heat a tumor, at levels that are usually safe for normal cells, to damage cancer cells. The treatment can be performed superfically or interstitally. This technology is the most advanced CT-and MRI-compatible treatment planning and delivery system available.